THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT
AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES.


Silvermet Inc. ("Silvermet" or the "Company") (TSX VENTURE:SYI) is pleased to
announce the release of its financial and operating results for Q3, 2011.


Highlights



--  Revenues in YTD-Q3 2011 increased by 15% to $12.8 million (at 100%)
    (Silvermet's share - $6.3 million) from $11.2 million in YTD-Q3 2010. 
--  The Company was cash flow positive and profitable. 
--  Operations continued to benefit from reduced smelter treatment charges
    in Q3 2011. 
--  Production in Q3 2011 reflected the stabilization of operations at 3,669
    DMT (Dry Metric Tonnes zinc concentrate containing 68.5% zinc on
    average) compared to Q3 2010 production of 3,615 DMT. 
--  Sales volume in YTD-Q3 2011 increased by 5% to 9,871 DMT from 9,421 DMT
    in YTD- Q3 2010) 
--  Revenues in Q3 2011 decreased by 15% to $4.0 million (at 100%)
    (Silvermet's share - $2.0 million) from $4.8 million in Q3 2010
    reflecting effect of timing of shipments and a declining zinc price
    trend in Q3 2011 compared to increasing prices in Q3 2010. 



The following table summarizes comparative quarterly results and reconciles net
earnings, a GAAP measure, to EBITDA. The 2010 figures reflect operational
results at 100% and 2011 figures reflect operational results at a proportionally
consolidated level of 49%.




----------------------------------------------------------------------------
                                   Three months ended September 30,         
                                      2011            2011             2010 
                                      100%    proportional             100% 
----------------------------------------------------------------------------
Gross sales revenues      $      4,042,257 $     1,980,706  $     4,753,062 
                                                                            
Direct operating costs           2,112,600       1,041,890        1,882,488 
Treatment &                                                                 
 transportation                  1,051,912         506,886        1,282,809 
Corporate costs                    114,636         114,636          341,616 
----------------------------------------------------------------------------
EBITDA(1)                 $        763,109 $       317,294  $     1,246,149 
----------------------------------------------------------------------------
                                                                            
Interest and financing                              27,932          146,029 
Amortization - Turkey                               70,486          115,258 
Amortization - Canada                                1,275            4,916 
Investment & other gain                             (4,949)        (201,731)
Foreign exchange loss                                                       
 (gain)                                            (61,153)         205,405 
Stock option expense                                19,710          267,253 
Income tax                                         149,564                - 
Non-controlling interest in net income of                                   
 consolidated affiliates                                 -          524,736 
----------------------------------------------------------------------------
Net income (loss) available to common                                       
 shareholders                              $       114,429  $       184,283 
----------------------------------------------------------------------------

----------------------------------------------------------------------------
                                    Nine months ended September 30,         
                                      2011            2011             2010 
                                      100%    proportional             100% 
----------------------------------------------------------------------------
Gross sales revenues      $     12,839,562 $     6,291,385  $    11,207,766 
                                                                            
Direct operating costs           6,199,183       2,959,079        6,372,187 
Treatment &                                                                 
 transportation                  3,388,928       1,560,065        3,528,950 
Corporate costs                    405,719         405,719          681,366 
----------------------------------------------------------------------------
EBITDA(1)                 $      2,845,732 $     1,366,522  $       625,263 
----------------------------------------------------------------------------
                                                                            
Interest and financing                             232,610          314,998 
Amortization - Turkey                              206,355          335,795 
Amortization - Canada                                3,256            8,674 
Investment & other gain                           (137,906)        (206,748)
Foreign exchange loss                                                       
 (gain)                                            (44,408)         154,913 
Stock option expense                                71,749          293,813 
Income tax                                         307,041                - 
Non-controlling interest                                                    
 in net income of                                                           
 consolidated affiliates                                 -          128,562 
----------------------------------------------------------------------------
Net income (loss)                                                           
 available to common                                                        
 shareholders                              $       727,825  $      (404,744)
----------------------------------------------------------------------------
(1) EBITDA is a non-GAAP measure, does not have a standardized meaning      
prescribed by GAAP and may not be comparable to similar terms and measures  
presented by other issuers. EBITDA comprises net income (loss) before income
taxes, interest and financing expense (including accretion of liabilities), 
amortization expense, gain on dilution, non-controlling interest and stock  
option expense. The Company believes it is appropriate to exclude stock     
option expense, gain on dilution and non-controlling interest from EBITDA as
a measure of operating performance that excludes non-recurring items.       



About Silvermet:

Silvermet's principal business activity is the recycling of electric arc furnace
dust ("EAFD") obtained from steel companies through a Waelz kiln to recover zinc
concentrates that are then sold to zinc smelters throughout the world. The
Company owns 49% of a joint venture, Befesa Silvermet Turkey S.L. ("BST"), which
operates a Waelz kiln facility located in Iskenderun, Turkey.


Caution concerning forward-looking statements: The information in this release
may contain forward-looking information under applicable securities laws. This
forward-looking information is subject to known and unknown risks, uncertainties
and other factors that may cause actual results to differ materially from those
implied by the forward-looking information. Factors that may cause actual
results to vary include, but are not limited to, inaccurate assumptions
concerning the exploration for and development of mineral deposits, political
instability, currency fluctuations, unanticipated operational or technical
difficulties, changes in laws or regulations, the risks of obtaining necessary
licenses and permits, changes in general economic conditions or conditions in
the financial markets and the inability to raised additional financing. Readers
are cautioned not to place undue reliance on this forward-looking information.
The Company does not assume the obligation to revise or update this
forward-looking information after the date of this release or to revise such
information to reflect the occurrence of future unanticipated events except as
may be required under applicable securities laws. The TSX Venture Exchange does
not accept responsibility for the adequacy or accuracy of this release.


Silvermet Inc. (TSXV:SYI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Silvermet Inc.
Silvermet Inc. (TSXV:SYI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Silvermet Inc.